XML 114 R79.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Share-based option plan (Tables)
12 Months Ended
Dec. 31, 2023
Compensation plans  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Disclosure of number and weighted average exercise prices of share options
The movement of the plans is as follows:
Number of shares
Description
Option plan
RSU
Phantom shares
Total
At December 31, 20213,923,6861,366,3865,136,68210,426,754
Granted17,089,4171,006,77918,096,196
Exercised(1,943,398)(479,098)(2,422,496)
Canceled(98,666)(4,810,210)(4,908,876)
At December 31, 202219,069,7051,795,401326,47221,191,578
Granted1,800,000500,0002,300,000
Exercised
(124,388)(609,313)(22,884)(756,585)
Canceled(223,633)(142,023)(56,658)(422,314)
At December 31, 202320,521,6841,544,065246,93022,312,679
Disclosure of range of exercise prices of outstanding share options
December, 31
Description20232022
Share price (in reais)16.01 11.01 
Weighted average price of the stock option (in reais)12.93 11.84 
Weighted average price of the phantom shares (in reais)10.35 
Cash inflow stock option plan1,60823,006
Flat cash inflow of phantom shares237
Total obligation related to the phantom shares 1,736 844 
Income tax regarding RSU transfer3,239 1,427 
The expenses of share-based compensation plans are shown below:
Years ended December, 31
Description202320222021
Option plan
61,646 29,368 5,933 
RSU 9,093 1,366 15,877 
Phantom shares904 (48,984)(4,630)
71,643 (18,250)17,180 
The reversal of expenses in 2022 and 2021 was due to the reduction in the fair value of shares in these periods.
Stock option plan  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Disclosure of range of exercise prices of outstanding share options
Disclosure of number and weighted average exercise prices of other equity instruments
During the third quarter of 2023, the Company granted one program with the following conditions:
Date of grantOption exercise price (in R$)Fair value of the option on the grant (in R$)Historical volatilityExpected dividendAverage risk-free rate of returnExercise rate per trancheDeadline remainder of vesting period (in years) Purchasing period up to (years)Total options grantedTotal outstanding options Total options available for exercise
December 11, 20093.42 1.93 47.7 %1.1 %8.8 %25.0 %0.04.05,032,800 182,870 182,870 
March 24, 20116.44 4.16 54.8 %1.1 %12.0 %25.0 %0.04.01,572,000 84,000 84,000 
April 5, 20116.44 4.16 54.8 %1.1 %12.0 %25.0 %0.04.0656,000 6,200 6,200 
June 30, 201419.15 11.01 40.6 %1.1 %12.5 %25.0 %0.04.02,169,122 708,993 708,993 
July 1, 201514.51 10.82 40.6 %1.1 %15.7 %25.0 %0.04.0627,810 177,592 177,592 
July 1, 201614.50 10.14 43.1 %1.1 %12.2 %25.0 %0.04.0820,250 280,124 280,124 
July 6, 201722.57 12.82 43.4 %1.1 %10.3 %25.0 %0.04.0680,467 442,796 442,796 
March 14, 201711.85 4.82 50.6 %1.1 %11.3 %20.0 %0.05.09,343,510 — — 
August 8, 202211.07 8.10 70.0 %— %13.0 %25.0 %2.64.01,774,418 1,731,390 439,962 
August 8, 202211.07 6.40 68.8 %— %13.2 %25.0 %1.64.01,514,999 1,399,999 669,500 
August 19, 202211.07 7.39 67.2 %— %13.6 %100.0 %0.01.04,900,000 4,824,333 4,824,333 
August 19, 202211.07 11.54 74.6 %— %12.7 %33.0 %3.65.08,900,000 8,900,000 — 
July 7, 202315.60 10.80 75.4 %— %11.6 %25.0 %3.54.01,800,000 1,783,387 — 
39,791,376 20,521,684 7,816,370 
Restricted stock options plan  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Disclosure of number and weighted average exercise prices of other equity instruments
During the third quarter the 2023, the Company granted one program with the following conditions:
Date of grantExercise rate per trancheFair value of share
(in reais)
Remaining term of the vesting period (in years)Purchasing period up to (years)Total
granted
Total not
exercised
July 7, 201925.0 %51.65 0.04.0170,000
June 19, 202025.0 %21.80 0.44.01,382,582255,126
July 7, 202125.0 %42.67 1.54.0300,000118,661
July 7, 202225.0 %11.72 2.54.0335,593230,693
July 7, 202225.0 %11.72 2.54.0671,186444,761
July 7, 202325.0 %19.32 3.54.0500,000494,824
3,359,3611,544,065
Phantom Shares  
Disclosure of terms and conditions of share-based payment arrangement [line items]  
Disclosure of number and weighted average exercise prices of other equity instruments
Date of grantOption exercise price
(in reais)
Average fair value of optionHistorical volatilityExpected dividendAverage risk-free rate of returnExercise rate per trancheRemaining term of the vesting period
(in years)
Purchasing period up to (years)Total grantedTotal outstanding Total options available for exercise
August 7, 2018
20.433.89 74.9 %%10.0 %25.0 %0.04.0707,400 53,520 53,520 
July 7, 2019
42.091.08 74.9 %%10.0 %25.0 %0.04.0405,000 — — 
April 30, 202010.357.87 74.9 %%10.0 %33.3 %0.03.03,250,000 153,160 153,160 
April 30, 202010.358.60 73.8 %%9.8 %25.0 %0.34.01,600,000 38,820 38,820 
August 17, 202133.993.46 71.4 %%9.8 %25.0 %1.64.0580,000 1,430 1,430 
6,542,400 246,930 246,930